The Middle East's Premier Reproductive Biotechnology Center
Elite Genetics. Preserved. Accessible. Revolutionary.
December 2025 | Dubai, UAE
Imagine elite camel genetics stored like high-value seeds on a shelf—not in endless tanks of liquid nitrogen. A breeder in a remote desert farm opens a vial, adds solution, and deposits genetics collected years earlier into ICSI to produce embryos.
No power cuts. No nitrogen deliveries. No distance constraints.
This is AN-MEP. This is the revolution we're leading.
400,000+
elite camels & horses in UAE alone
AED 3.2B+
annual market spend (regional)
Zero
integrated full-service providers in GCC
Al-Shababi targets 2-3% market share by Year 5 = AED 65-100M+ revenue
Breeders juggle embryo transfer clinics + genetics labs + preservation facilities
Expensive infrastructure, power dependency, geographic isolation
Genetics, breeding records, and embryo data scattered across providers
No integrated R&D driving next-gen techniques like room-temperature preservation
One Partner. Complete Genetics Management. From Collection to Breeding.
Room-temperature AN-MEP storage eliminates nitrogen dependency
Full genome archival with lifetime accessibility
ICSI, IVF, embryo transfer, cloning all integrated
Single source of truth for genetics, breeding records, embryo outcomes
Real-time insights connecting genetics to outcomes
Result: Breeders go to ONE partner instead of juggling multiple clinics, labs, and storage facilities. Better outcomes. Lower cost. Faster scaling.
Single Data Architecture • Integrated Outcomes Tracking • One Client Portal
Antioxidant Nanocarrier-Mediated Encapsulated Preservation
Trehalose-based lyophilization + antioxidant nanoparticles + oxygen-controlled packaging
2-5 years at 4-25°C (no liquid nitrogen, no power dependency)
Genomically intact sperm ready for ICSI and embryo production
Decentralizes elite genetics—breeders can store, ship, and use whenever needed
First results: 6 months of operation | Full commercialization: 18-24 months R&D validation
AED 60-80M Revenue Target
Multiple Revenue Streams. One Integrated Delivery.
42-54M AED
Core service: Genetic delivery to recipients. Data feeds cloning & gene banking.
12-16M AED
Lifetime genetic archival. Enables cloning & future breeding decisions.
6-8M AED
Embryo production backbone. Works with all preservation & genetics.
4-6M AED
Premium services. AN-MEP integrates with embryo transfer + genetics.
Key insight: Each service amplifies the others. Embryo transfer drives gene banking demand. Genetics archives enable cloning. AN-MEP preserves valuable genetics. One client, one platform, exponential value.
Competitors offer single services (embryo transfer OR cloning OR banking). We offer all integrated. Clients have zero switching cost—why go elsewhere?
Each service generates data. More data = better breeding intelligence. Better intelligence = more clients. Defensible moat.
Proprietary room-temperature preservation. Competitors cannot replicate in less than 2 years. Massive operational & cost advantage.
Integrated delivery reduces marginal costs. We can undercut fragmented competitors on price while maintaining margins.
First integrated player in GCC breeding market locks in elite clients, leaving no viable openings for competitors.
CEO
Strategic leadership & business operations
Chief Scientific Officer
Embryo transfer & reproductive protocols
Business & Strategic Operator
Go-to-market, partnerships, scaling
Head of Pharmaceuticals
Gene banking & preservation protocols
Elite Animal Specialist
Breeding expertise, client relationships
Tech, Ops, Regulatory
Cloning, lab management, compliance
Dubai lab finalized, equipment installed, team onboarded
AN-MEP & embryo transfer SOP locked, regulatory pre-approval
First clients onboarded, initial results & validation
Regional expansion, 18-month AN-MEP validation cycle begins
~AED 8-10M
~AED 12-20M
Use of funds: Facility & equipment 40%, operations & team 50%, working capital/contingency 10%
Elite breeder partnerships—focus on high-value clients with 10+ breeding animals
Regional expansion—Saudi, Qatar, Kuwait partnerships with local veterinary networks
GCC-wide presence—establish satellite collection points, centralized Dubai hub
Direct breeder relationships + veterinary partnership network + royal patronage leverage
Target: 2-3% of GCC breeding services market = AED 65-100M+ annual revenue by Year 5
Challenge: DHDC approval timeline
Mitigation: Early engagement, pre-approved SOPs, experienced regulatory team
Challenge: Team hiring, lab setup delays
Mitigation: Parallel workstreams, experienced project manager, contingency timeline
Challenge: Breeder education & trust
Mitigation: Partnerships with industry leaders, early validation, case studies
Challenge: AN-MEP validation
Mitigation: R&D team in place, 18-month validation plan, backup approaches ready
Challenge: Incumbent clinics
Mitigation: First-mover advantage, integrated model + innovation defense IP
AED 3.2B+ regional breeding services market; zero integrated competition
First-mover with room-temperature preservation—defensible technology advantage
AED 60-80M Year 1 revenue, 42-48% EBITDA by Year 5, 3-3.5 year payback
Elite genetics, heritage preservation, biotech innovation, high-value agriculture
AED 20-30 Million Capital
Full funding for 2026 launch and first-year operations
Greenlight Authority: Execute master plan with quarterly updates to H.H. and board
Timeline: Funding close by January 2026 to meet Q1 facility setup milestones
By 2031, Al-Shababi will be the integrated genetics powerhouse every elite breeder in the GCC turns to first—for collection, preservation, genetics, reproduction, and outcomes.
Full-service integration. Zero switching costs. Exponential value.